{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:27:28Z","timestamp":1779186448014,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.eclinm.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T16:50:09Z","timestamp":1562172609000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Madeleine","family":"Rooney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Pilkington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Gardner-Medwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rangaraj","family":"Satyapal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqui","family":"Clinch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rejina","family":"Verghis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2019.06.004_bb0005","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/art.27516","article-title":"Quantification of the familial contribution to juvenile idiopathic arthritis","volume":"62","author":"Prahalad","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02555248","article-title":"Vertebral collapse in juvenile chronic arthritis: its relationships with glucocorticoid therapy","volume":"41","author":"Varamos","year":"1987","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0015","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/ard.51.11.1223","article-title":"Bone resorption by cells isolated from rheumatoid synovium","volume":"51","author":"Chang","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0049-0172(90)90022-8","article-title":"Nutritional status and growth in juvenile rheumatoid arthritis","volume":"20","author":"Bacon","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0025","first-page":"41073","article-title":"Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis","volume":"27","author":"Rooney","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/35.4.309","article-title":"Bone mass measurement and bone metabolism in rheumatoid arthritis: a review","volume":"35","author":"Deodhar","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"Suppl,2","key":"10.1016\/j.eclinm.2019.06.004_bb0035","first-page":"212","article-title":"Growth retardation in juvenile rheumatoid arthritis","volume":"20","author":"Bernstein","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1542\/peds.91.6.1127","article-title":"Estimation of central osteopenia in children with chronic polyarthritis treated with glucocorticoids","volume":"91","author":"Kotiani","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0169-6009(90)90081-P","article-title":"Bone metabolism in juvenile rheumatoid arthritis","volume":"9","author":"Bianchi","year":"1990","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.eclinm.2019.06.004_bb0050","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4146","article-title":"Oral corticosteroid prescribing for children with asthma in a Medicaid Managed Care Program","volume":"139","author":"Farber","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.eclinm.2019.06.004_bb0055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","article-title":"Children and the risk of fractures caused by oral corticosteroids","volume":"18","author":"van Staa","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.eclinm.2019.06.004_bb0060","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-3476(06)80006-5","article-title":"Repair of osteopenia in children with juvenile rheumatoid arthritis","volume":"122","author":"Reed","year":"1993","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.eclinm.2019.06.004_bb0065","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/acr.23279","article-title":"2017 American College of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"24","key":"10.1016\/j.eclinm.2019.06.004_bb0070","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199306173282404","article-title":"Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin","volume":"328","author":"Sambrook","year":"1993","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2019.06.004_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s001980050118","article-title":"Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis","volume":"9","author":"Reginster","year":"1999","journal-title":"Osteoporosis Int"},{"issue":"9","key":"10.1016\/j.eclinm.2019.06.004_bb0080","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J","article-title":"2000 Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study","volume":"43","author":"Bianchi","year":"2000","journal-title":"Arth & Rheum"},{"issue":"6","key":"10.1016\/j.eclinm.2019.06.004_bb0085","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/rheumatology\/keh538","article-title":"Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment","volume":"44","author":"Rudge","year":"2005","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.eclinm.2019.06.004_bb0090","article-title":"Bisphosphonate therapy for children and adolescents with secondary osteoporosis","volume":"17","author":"Ward","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.eclinm.2019.06.004_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1756-185X.12560","article-title":"Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review","volume":"18","author":"Jayasena","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0100","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/clinchem\/48.4.671","article-title":"Serum crosslaps: paediatric reference intervals from birth to 19 years of age","volume":"48","author":"Crofton","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0105","unstructured":"Crabtree NJ, Oldroyd B, Bishop NJ, et al A paediatric lumbar spine phantom for inter-site and inter-machine cross-calibration. In: Bone 2005 36(5) Suppl 1. S44."},{"key":"10.1016\/j.eclinm.2019.06.004_bb0110","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/sim.4780111005","article-title":"Smoothing reference centile curves: the lms method and penalized likelihood","volume":"11","author":"Cole","year":"1992","journal-title":"Statist Med"},{"issue":"1","key":"10.1016\/j.eclinm.2019.06.004_bb0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jbmr.2935","article-title":"Amalgamated reference data for size-adjusted bone densitometry measurements in 3598 children and young adults-the ALPHABET Study","volume":"32","author":"Crabtree","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0120","doi-asserted-by":"crossref","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8:1137\u20131148.","DOI":"10.1002\/jbmr.5650080915"},{"issue":"5","key":"10.1016\/j.eclinm.2019.06.004_bb0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced osteoporosis intervention study group","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"issue":"9041","key":"10.1016\/j.eclinm.2019.06.004_bb0130","first-page":"1535","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Fracture Intervention Trial Research Group Lancet"},{"issue":"9902","key":"10.1016\/j.eclinm.2019.06.004_bb0135","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Bishop","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0140","unstructured":"Green R P Washington University Medical School-St. Louis Children's Hospital St. Louis, Missouri, USA Clinical Trials.gov identifier NCT00022841."},{"key":"10.1016\/j.eclinm.2019.06.004_bb0145","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1440-1754.2005.00720.x","article-title":"Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents","volume":"41","author":"Brown","year":"2005","journal-title":"J Paediatr Child Health"},{"issue":"7289","key":"10.1016\/j.eclinm.2019.06.004_bb0150","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/bmj.322.7289.799\/a","article-title":"Complications with reformulated one-alpha vit D","volume":"322","author":"Savage","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2019.06.004_bb0155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00198-009-0973-3","article-title":"Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases","volume":"21","author":"Park","year":"2010","journal-title":"Osteoporosis Int"},{"issue":"5","key":"10.1016\/j.eclinm.2019.06.004_bb0160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11914-017-0401-0","article-title":"Long-term bisphosphonate therapy in osteogenesis imperfecta","volume":"15","author":"Biggin","year":"2017","journal-title":"Curr Osteoporos Rep"}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537019300975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537019300975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:00:19Z","timestamp":1762887619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537019300975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":32,"alternative-id":["S2589537019300975"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2019.06.004","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}